Corticosteroid plus alkylating agent combination

This page covers all Corticosteroid plus alkylating agent combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

• prednisone plus cyclophosphamide · Guangdong Provincial People's Hospital · Immunology / Oncology
  Prednisone suppresses immune and inflammatory responses while cyclophosphamide acts as an alkylating agent to kill rapidly dividing cells, together providing immunosuppression and cytotoxic effects.

Patent intelligence

• corticosteroid plus alkylating agent combination patent landscape — aggregated cliff calendar, attackable patents, originator estates